Literature DB >> 28336351

Proposed Medicare Coverage for Diabetes Prevention: Strengths, Limitations, and Recommendations for Improvement.

Natalie D Ritchie1, Edward P Havranek2, Susan L Moore3, Rocio I Pereira4.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28336351     DOI： 10.1016/j.amepre.2017.02.005

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN： 0749-3797            Impact factor:   5.043


× No keyword cloud information.
  5 in total

1.  A Multilevel Diabetes and CVD Risk Reduction Intervention in African American Churches: Project Faith Influencing Transformation (FIT) Feasibility and Outcomes.

Authors:  Jannette Berkley-Patton; Carole Bowe Thompson; Alexandria G Bauer; Marcie Berman; Andrea Bradley-Ewing; Kathy Goggin; Delwyn Catley; Jenifer E Allsworth
Journal:  J Racial Ethn Health Disparities       Date:  2020-04-23

Review 2.  Behavior Modification in Prediabetes and Diabetes: Potential Use of Real-Time Continuous Glucose Monitoring.

Authors:  Nicole Ehrhardt; Enas Al Zaghal
Journal:  J Diabetes Sci Technol       Date:  2018-08-01

3.  Challenges with implementing the Diabetes Prevention Program for Medicare beneficiaries in an integrated health system.

Authors:  Inga Gruß; Alison Firemark; Dea Papajorgji-Taylor; Stephanie L Fitzpatrick
Journal:  Am J Manag Care       Date:  2021-11-01       Impact factor: 3.247

4.  Optimization of a technology-supported physical activity intervention for breast cancer survivors: Fit2Thrive study protocol.

Authors:  Siobhan M Phillips; Linda M Collins; Frank J Penedo; Kerry S Courneya; Whitney Welch; Alison Cottrell; Gillian R Lloyd; Kara Gavin; David Cella; Ronald T Ackermann; Juned Siddique; Bonnie Spring
Journal:  Contemp Clin Trials       Date:  2018-01-09       Impact factor: 2.226

Review 5.  Current Perspectives on the Impact of the National Diabetes Prevention Program: Building on Successes and Overcoming Challenges.

Authors:  Natalie D Ritchie; Katherine J W Baucom; Katherine A Sauder
Journal:  Diabetes Metab Syndr Obes       Date:  2020-08-19       Impact factor: 3.168
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.